Successful use of rituximab for hydralazine-induced anti-neutrophil cytoplasmic antibodies-associated vasculitis

Successful use of rituximab for hydralazine-induced anti-neutrophil cytoplasmic antibodies-associated vasculitis

Hydralazine is a commonly used anti-hypertensive medication. It can, however, contribute to the development of autoimmunity, in the form of drug-induced lupus and anti-neutrophil cytoplasmic antibodies-associated vasculitis. We report a 45-year-old patient with hypertension managed with hydralazine...

Full description

Bibliographic Details
Main Authors: Michael A Paley, Fahad Edrees, Satoru Kudose, Joseph P Gaut, Prabha Ranganathan, Anitha Vijayan
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Saudi Journal of Kidney Diseases and Transplantation
Online Access:http://www.sjkdt.org/article.asp?issn=1319-2442;year=2019;volume=30;issue=1;spage=226;epage=230;aulast=Paley

Internet

http://www.sjkdt.org/article.asp?issn=1319-2442;year=2019;volume=30;issue=1;spage=226;epage=230;aulast=Paley

Similar Items